Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Teleflex Inc (TFX)

Teleflex Inc (TFX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,045,058
  • Shares Outstanding, K 46,801
  • Annual Sales, $ 2,537 M
  • Annual Income, $ 335,320 K
  • 60-Month Beta 1.19
  • Price/Sales 7.12
  • Price/Cash Flow 25.20
  • Price/Book 5.38
Trade TFX with:

Options Overview

Details
  • Implied Volatility 33.85%
  • Historical Volatility 23.92%
  • IV Percentile 62%
  • IV Rank 43.16%
  • IV High 46.29% on 10/28/20
  • IV Low 24.40% on 07/02/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 184
  • Volume Avg (30-Day) 172
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,095
  • Open Int (30-Day) 795

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 3.05
  • Number of Estimates 10
  • High Estimate 3.11
  • Low Estimate 2.97
  • Prior Year 2.77
  • Growth Rate Est. (year over year) +10.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
369.06 +4.47%
on 08/19/21
405.89 -5.01%
on 09/08/21
+7.23 (+1.91%)
since 08/17/21
3-Month
359.57 +7.23%
on 08/13/21
428.36 -9.99%
on 07/09/21
-17.46 (-4.33%)
since 06/17/21
52-Week
312.33 +23.45%
on 10/30/20
449.38 -14.20%
on 04/28/21
+38.99 (+11.25%)
since 09/17/20

Most Recent Stories

More News
North America & Europe Oxygen Therapy Market- Outlook with Trends, Types, Applications, and Opportunity Outlook 2028

Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

BDX : 261.95 (-0.27%)
TFX : 385.57 (-0.10%)
GE : 100.47 (-0.86%)
AHPI : 7.66 (+3.93%)
FPH : 7.85 (-1.88%)
Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures at the American Urological Association 2021 Annual Meeting

Teleflex Incorporated (NYSE:TFX) today announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift System among the analyzed...

TFX : 385.57 (-0.10%)
Percutaneous Coronary Intervention Market- Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2027

Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

ABT : 126.79 (-0.51%)
BSX : 44.37 (-1.18%)
MDT : 129.70 (-0.93%)
TFX : 385.57 (-0.10%)
BDX : 261.95 (-0.27%)
Teleflex (TFX) Real-World Data Outcome Supports UroLift System

Teleflex's (TFX) new real-world data outcomes together with product launches demonstrate the importance of UroLift System for most BPH patients.

HSIC : 77.47 (-1.15%)
TFX : 385.57 (-0.10%)
NVST : 42.53 (-2.12%)
BRBR : 31.85 (+0.38%)
Surgical Sutures Market Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2027 | Impact of COVID-19 Pandemic

Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2027"which delivers detailed overview of the global surgical sutures market in terms of market segmentation by...

JNJ : 164.75 (-0.28%)
MDT : 129.70 (-0.93%)
CNMD : 130.03 (-1.25%)
TFX : 385.57 (-0.10%)
Teleflex Unveils the UroLift Advanced Tissue Control (ATC)(R) System and the UroLift(R) 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting

New real-world data findings along with new product evolutions demonstrate why the UroLift System is the right solution for most BPH patients

TFX : 385.57 (-0.10%)
New Study Provides Insights into the Biocompatibility and Durability of the UroLift(R) System in Improving Benign Prostatic Hyperplasia Symptoms

Teleflex Incorporated (NYSE: TFX) today announced the publication of clinical data for the UroLift System in the peer-reviewed journal Prostate Cancer and Prostatic Disease. This study explains the mechanism...

TFX : 385.57 (-0.10%)
Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo 2021 Virtual Healthcare Conference on Thursday, September 9, 2021 at 12:40 p.m. (ET)....

WFC : 46.47 (+0.41%)
TFX : 385.57 (-0.10%)
Teleflex (TFX) Rides on UroLift Growth, Hurt by Pandemic Woes

Teleflex (TFX) has decided to increase its investment in 2021 and run a national campaign for the full year.

ISRG : 1,037.27 (+0.32%)
TFX : 385.57 (-0.10%)
IDXX : 661.71 (-0.26%)
SMLR : 108.7200 (+1.59%)
Teleflex (TFX) Q2 Earnings Surpass Estimates, Margins Up

Teleflex (TFX) reports better-than-expected revenues with strong segmental and geographical performance driving the top line in second-quarter 2021.

BSX : 44.37 (-1.18%)
LH : 295.93 (-0.30%)
TFX : 385.57 (-0.10%)
WST : 448.62 (-1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors....

See More

Key Turning Points

3rd Resistance Point 393.73
2nd Resistance Point 390.80
1st Resistance Point 388.19
Last Price 385.57
1st Support Level 382.65
2nd Support Level 379.72
3rd Support Level 377.11

See More

52-Week High 449.38
Fibonacci 61.8% 397.02
Last Price 385.57
Fibonacci 50% 380.85
Fibonacci 38.2% 364.68
52-Week Low 312.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar